1. Ilott I, Rick J, Patterson M, Turgoose C, Lacey A. What is protocol-based care? A concept analysis. J Nurs Manag. 2006;14(7):544-52. doi: 10.1111/j.1365-2934.2006.00703.x.

2. Gulwani S. Programming by examples: Applications, algorithms, and ambiguity resolution. Redmond, WA: Microsoft Corporation; 2016.

3. American Cancer Society (ACS). Biopsia por aspiración con aguja fina [Internet]. Atlanta (GA): ACS [updated 2019 Oct 3; cited 2022 Dec 4]. Available from: https://www.cancer.org/es/cancer/cancer-de-seno/pruebas-de-deteccion-y-detecciontemprana-del-cancer-de-seno/biopsia-del-seno/biopsia-del-seno-por-aspiracion-conaguja-fina.html.

4. Carlosama-Rosero Y, Gutiérrez NR, Rolón MC, Rosero EA. Biopsia por congelación: recomendaciones en la práctica clínica y dermatológica. Rev Colomb Cancerol. 2014;18(2):88-91. doi: https://doi.org/10.1016/j.rccan.2014.03.002.

5. American Cancer Society (ACS). Detección temprana y diagnóstico del cancer de seno [Internet]. Atlanta (GA): ACS; 2019 [updated 2019 Oct 3; cited 2022 Dec 4]. Available from: https://www.cancer.org/content/dam/CRC/PDF/Public/9019.00.pdf.

6. MedlinePlus. Evaluación citológica [Internet]. Bethesda (MD): MedlinePlus; 2021 [updated 2021 Jul 7; cited 2022 Dec 4]. Availabe from: https://medlineplus.gov/spanish/ency/article/002323.htm#:~:text=Es%20el%20an%C3 %A1lisis%20de%20c%C3%A9lulas,infecciones%20virales%20en%20las%20c%C3% A9lulas.

7. Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017;27(11):1341-6. doi: 10.1089/thy.2017.0500.

8. Jun G, Ward J, Morris Z, Clarkson J. Health care process modelling: which method when? Int J Qual Health Care. 2009;21(3):214- 24. doi: 10.1093/intqhc/mzp016.

9. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.

10. Corrales-Hernández JJ, Iglesias DM, Gómez-Alfonso FJ. Microcarcinoma papilar de tiroides. ¿Es necesario el tratamiento con 131I tras la cirugía? Argumentos a favor. Endocrinol Nutr. 2006;53(6):390-8. doi: https://doi.org/10.1016/S1575-0922(06)71121- 4.

11. Román-González A, Restrepo-Giraldo L, Alzate-Monsalve C, Vélez A, GutiérrezRestrepo J. Nódulo tiroideo, enfoque y manejo. Revisión de la literatura. Iatreia. 2013;26(2):197-206.

12. Mayor Clinic. Nódulos tiroideos [Internet]. Rochester: Mayo Clinic; 2022 [updated 2022 Feb 11; cited 2022 Dec 4]. Available from: https://www.mayoclinic.org/es-es/diseasesconditions/thyroid-nodules/symptoms-causes/syc-20355262.

13. Ochoa-Sosa CA, Handal-Gamundi VK, Gómez-Cruz JR, González-Villaseñor GA, Arechavaleta-Granell R, Bolaños-Gil De Montes F, et al. Guía para el uso del I131 en pacientes con cáncer diferenciado de tiroides, Sociedad Mexicana de Nutrición y Endocrinología, A.C. Rev Mex Endocrinol Metab Nutr. 2018;5(4):160-84.

14. Caballero Loscos C, Mateo-Martin AB, Orduña-Diez MP, Cordero-García JM, CrespoDiez A. Falsos positivos del rastreo corporal total con 131I en el cancer diferenciado de tiroides. Endocrinol Nutr. 1999;46(10):330-5.

15. National Cancer Institute. NCI Dictionary of Cancer Terms “ajuvant therapy” [Internet]. Bethesda (MD): National Institutes of Health [cited 2022 Dec 4]. Available from: https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionariocancer/def/terapia-adyuvante.

16. Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, et al. n ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009;94(5):1748-51. doi: 10.1210/jc.2008-1724.

17. Shahid MA, Ashraf MA, Sharma S. Physiology, Thyroid Hormone. 2022. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–.

18. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-9. doi: 10.3322/caac.21388.

19. Feldt-Rasmussen U, Høier-Madsen M, Bech K, Blichert-Toft M, Bliddal H, Date J, et al. Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. Autoimmunity. 1991;9(3):245-54. doi: 10.3109/08916939109007650.

20. Cleveland Clinic. Thyroid Nodules [Internet]. Cleveland: Cleveland, Clinic; 2022 [updated 2022 Jun 6; cited 2022 Dec 4]. Available from: https://my.clevelandclinic.org/health/diseases/13121-thyroid-nodule.

21. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE. Endocr Pract. 2016;22(5):622-39. doi: 10.4158/EP161208.GL.

22. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. doi: 10.1089/thy.2015.0020.

23. Rossi ED, Pantanowitz L, Hornick JL. A worldwide journey of thyroid cancer incidence centred on tumour histology. Lancet Diabetes Endocrinol. 2021;9(4):193-4. doi: 10.1016/S2213-8587(21)00049-8.

24. Cuervo-Martínez JA, Osorio-Luz K, Romero-Rojas AE, Olaya-Morales N. Caracterización clínica e histopatológica del carcinoma papilar de tiroides en el instituto nacional de cancerología E.S.E., bogotá-colombia durante los años 2006 a 2012. Revista Colombiana de Cancerología. 2013;17(4):138. doi: 10.1016/S0123-9015(13)70217-8.

25. Hernández-Flórez CE. Cáncer de tiroides en Colombia, un común desconocido. Méd. UIS. 2018;31(3):9-11.

26. Wandurraga-Sánchez EA, Marín-Carrillo LF, Natera-Melo AK, Gómez-Giraldo CM, Niño-Prato F, Arenas-Quintero HM, et al. Características clínicas, histopatológicas y terapéuticas del cáncer de tiroides en Colombia: serie de 1.096 pacientes. Revista Colombiana de Endocrinología, Diabetes y Metabolismo. 2019;6(1):5-12.

27. Carling T, Udelsman R. Thyroid Cancer. Annu Rev Med. 2014;65(1):125-37. doi: 10.1146/annurev-med-061512-105739.

28. Zaridze D, Maximovitch D, Smans M, Stilidi I. Thyroid cancer overdiagnosis revisited. Cancer Epidemiol 2021;74:102014. doi: 10.1016/j.canep.2021.102014.

29. LiVolsi VA. Papillary thyroid carcinoma: an update. Mod Pathol. 2011;24(S2):S1-9. doi: 10.1038/modpathol.2010.129.

30. Jung CK, Baek JH, Na DG, Oh YL, Yi KH, Kang HC. 2019 practice guidelines for thyroid core needle biopsy: A report of the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association. J Pathol Transl Med. 2020;54(1):64-86. doi: 10.4132/jptm.2019.12.04.

31. Brouwers MC, Kerkvliet K, Spithoff K; AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016;i1152. doi: 10.1136/bmj.i1152.

32. Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, et al. he American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg. 2020;271(3):e21-93. doi: 10.1097/SLA.0000000000003580.

33. National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Thyroid Carcinoma V.3.2018 [Internet]. Plymouth Meeting (PA): NCCN; 2018. Available from: https://www.nccn.org/guidelines/guidelines-process/transparency-process-andrecommendations/GetFileFromFileManagerGuid?FileManagerGuidId=844779b7-06b9- 4ce0-b5ab-46bc5bacd986.

34. Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard BA G, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81(Supp 1):1-122. doi: 10.1111/cen.12515.

35. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-214. doi: 10.1089/thy.2009.0110.

36. Lewandowski K. Reference ranges for TSH and thyroid hormones. Thyroid Res. 2015;8(Suppl 1):A17. doi: 10.1186/1756-6614-8-S1-A17.

37. Leboulleux S, Girard E, Rose M, Travagli JP, Sabbah N, Caillou B, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab. 2007;92(9):3590-4. doi: 10.1210/jc.2007-0444.

38. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TIRADS Committee. J Am Coll Radiol. 2017;14(5):587-95. doi: 10.1016/j.jacr.2017.01.046.

39. Grant EG, Tessler FN, Hoang JK, Langer JE, Beland MD, Berland LL, et al. Thyroid Ultrasound Reporting Lexicon: White Paper of the ACR Thyroid Imaging, Reporting and Data System (TIRADS) Committee. J Am Coll Radiol. 2015;12(12 Pt A):1272-9. doi: 10.1016/j.jacr.2015.07.011.

40. Bonavita JA. Sonographic Patterns of Benign Thyroid Nodules. Am J Roentgenol. 2012;198(1):W102-3. doi: 10.2214/AJR.11.7737.